{
    "title": "CSL first half profit up 11% to $1.86bn",
    "url": "https://www.dailymail.co.uk/wires/aap/article-7993069/CSL-half-profit-11-1-25bn.html",
    "date": "2020-02-11",
    "keywords": [
        "cent",
        "year",
        "csl",
        "profit",
        "revenue",
        "currency",
        "basis",
        "effort",
        "blood",
        "csls",
        "immunoglobulin",
        "demand",
        "perreault",
        "half",
        "company",
        "influenza",
        "vaccine",
        "dividend",
        "biotech",
        "giant",
        "leap",
        "guidance",
        "manufacturer",
        "period",
        "run",
        "start",
        "aedt",
        "trading",
        "growth",
        "increase",
        "execution",
        "strategy",
        "passion",
        "executive",
        "director",
        "paul",
        "bestselling",
        "antibody",
        "privigen",
        "hizentra",
        "immunodeficiency",
        "disorder",
        "cipd",
        "inflammatory",
        "polyneuropathy",
        "supply",
        "collection",
        "track",
        "halfyear",
        "haemophilia",
        "flu",
        "qqiv",
        "australia",
        "protein",
        "albumin",
        "distribution",
        "model",
        "mr",
        "wuhan",
        "coronavirus",
        "area",
        "expertise",
        "technology",
        "university",
        "queensland",
        "share",
        "net"
    ],
    "category": [
        "wires",
        "aap"
    ]
}